Nasser Altorki on Lung Cancer Radiotherapy and Immune Checkpoint Blockade in the Neoadjuvant Setting – The ASCO Post
Nasser K. Altorki, MD, of Weill Cornell Medical College, discusses study findings that suggest neoadjuvant low-dose focal stereotactic body radiation plus immune checkpoint blockade (ICB) is safe and causes no surgical delays in early-stage lung cancer, and that major pathologic response rates are likely to be comparable to those with chemotherapy/ICB combinations (Session ED37 ). …
